Abstract: A new chewing gum comprising a gum member, with a central core or cavity, and a core element located within the central core or cavity. The chewing gum also comprises a dietary supplement, which may be incorporated in the central core, the cavity, or both. The core element can be of a range of consistencies, from fluid to gel-like. Optionally, the gum member may comprise crystals. Additionally, the crystals may comprise a dietary supplement. The chewing gum may be encapsulated with a coating. Multiple dietary supplements, of different or of the same varieties, may be incorporated into the chewing gum.
Abstract: Copper (I) chloride complex of nicotinic acid and pharmaceutical compositions containing the same. Such pharmaceutical composition are effective for the treatment of myopathy, myasthenia gravis, parkinsonism, Chronic Fatigue Syndrome, Male Infertility and post stroke muscle weakness, muscular dystrophy, skin burns, scars, alopecia, high blood lipids and obesity.
Abstract: Disclosed is a composition and method for providing antimicrobial protection to plastic structures, such as plastic decking, planking, fencing, and panels. The method comprises applying a water-soluble biocide to the metal-containing structure, and converting the soluble biocide to a water-insoluble metal biocide salt that is adsorbed on the surface of, or into the porous structure of the plastic material. The slow release of the insoluble antimicrobial agent from the surface or from within the pores of said plastic structure provides antimicrobial protection for the plastic structure.
Type:
Application
Filed:
January 25, 2011
Publication date:
May 26, 2011
Inventors:
Bonnie B. Sandel, Richard H. Dumas, Patricia A. Turley
Abstract: The present invention provides for compositions and methods that may offer protection from irritants as well as antimicrobial protection. Preferred embodiments of the invention include topical antimicrobial compositions that lack conventional antibiotics or preservatives, wherein the antimicrobial benefit is created by essential oils (or their active ingredients), emollient solvents and, in some instances, anti-inflammatory agents.
Type:
Application
Filed:
December 17, 2010
Publication date:
May 19, 2011
Inventors:
Shanta M. Modak, Trupti Gaonkar, Milind Shintre, Lauserpina Caraos
Abstract: The invention relates to ether guanidines of the general formulae (I) and/or salts or hydrates thereof, in which R1=—CH2—CH2—CH2—O—R3 where R3 is, independently of the others, hydrocarbon radicals having greater than or equal to 10 carbon atoms, where part of the ether guanidines has radicals R3 which are branched and part of the ether guanidines has radicals R3 which are unbranched, and R2=independently of the others H or an optionally branched, optionally double-bond-containing hydrocarbon radical having 1 to 30 carbon atoms, and use thereof in hair treatment compositions and hair aftertreatment compositions, in particular for preventing damage by chemical treatment compositions and for repairing hair which is already damaged.
Type:
Application
Filed:
May 28, 2009
Publication date:
May 19, 2011
Applicant:
EVONIK GOLDSCHMIDT GMBH
Inventors:
Oliver Springer, Peter Muss, Burghard Gruening, Ursula Maczkiewitz, Mike Farwick, Peter Lersch
Abstract: The present invention relates to a cell-targeting complex comprising a targeting moiety and a deliverable compound, wherein said targeting moiety and said deliverable compound are joined by means of a (transition) metal ion complex having at least a first reactive moiety for forming a coordination bond with a reactive site of said targeting moiety and having at least a second reactive moiety for forming a coordination bond with a reactive site of said deliverable compound, and wherein said deliverable compound is a therapeutic compound.
Type:
Application
Filed:
July 20, 2006
Publication date:
May 5, 2011
Applicant:
KREATECH BIOTECHNOLOGY B.V.
Inventors:
Robert Jochem Heetebrij, Robbert Jan Kok, Eduard Gerhard Talman, Klaas Poelstra, Grietje Molema
Abstract: Methods for preventing and treating damage to the optic nerve and/or retina by the use of SOD mimics, particularly pentaazacycle Mn(II) complex SOD mimics, are disclosed.
Abstract: The present invention comprises cosmetic compositions and methods for retarding hair growth comprising a combination of an ornithine decarboxylase inhibitor, an anti-angiogenic active and an anti-inflammatory.
Type:
Application
Filed:
May 25, 2010
Publication date:
May 5, 2011
Inventors:
Mindy S. Goldstein, Chia Wen Chen, Christina G. Fthenakis, Kenneth D. Marenus, Thomas Mammone
Abstract: The present disclosure is related to a pharmaceutical composition for treatment of cancer comprising a cyclometalated N-heterocyclic carbene complex. The cyclometalated N-heterocyclic carbene complex contains a gold(III) or a platinum(II) atom. The pharmaceutical composition possesses anti-cancer activity such as the induction of cell death, inhibition of cellular proliferation, inhibition of topoisomerase and/or poisoning of topoisomerase.
Type:
Application
Filed:
October 27, 2010
Publication date:
April 28, 2011
Applicant:
THE UNIVERSITY OF HONG KONG
Inventors:
Chi Ming Che, Raymond Wai-Yin Sun, Lok Fung Chow, Jing Yan
Abstract: This document provides methods and materials related to managing weight, supporting appetite control, and controlling cravings associated with smoking reduction or cessation regimens and/or nicotine reduction or cessation regimens. For example, compositions comprising an agent to support acetylcholine and an agent to support one or more biogenic amines, and methods for using such compositions for craving and appetite control are provided. Methods and materials to reduce cravings associated with the reduction or cessation of the use of chemical substances (e.g., drugs of abuse, including opioids, cocaine, methamphetamine, cannabis, alcohol), and to reduce cravings associated with addictive and/or compulsive behaviors (e.g., gambling, sex, and repetitive behaviors) are also provided.
Type:
Application
Filed:
October 28, 2010
Publication date:
April 28, 2011
Applicant:
NEUROSCIENCE, INC.
Inventors:
Michael J. Bull, Gottfried H. Kellermann, Kelly L. Olson
Abstract: The present invention provides a compound of formula (I): PtIV(N3)2X1X2Y1Y2, wherein X1 and X2 are the same or different and each one is a group NR1R2R3 wherein R1, R2 and R3 are the same or different and each can be any one of H and optionally substituted alkyl, aryl, aralkyl, acyl, cycloalkyl, heterocyclyl, alkenyl, aralkenyl, alkinyl, cycloalkenyl, or X1 and X2 together represent a group R1R2NR4NR1R2 wherein R1 and R2 have the same meaning as before, and R4 represents an optionally substituted divalent, saturated or unsaturated, alkyl chain, an optionally substituted divalent, saturated or unsaturated cycloalkyl or an optionally substituted divalent aryl, or R4 or two or more of R1, R2, R3 and R4 and the respective N atom(s) to which they are linked, represent an optionally substituted heterocyclyl having at least one ring containing said N atom(s); and Y1 and Y2 are the same or different or when cis together represent a divalent moiety Y3, wherein at least one of Y1 and Y2, or Y3, is a substantially labil
Abstract: The present invention relates to compositions comprising quaternary ammonium compounds and essential oils or individual constituents thereof which exhibit enhanced antimicrobial effects. Such combinations may be comprised in lotions, gels, creams, soaps, etc. for application to skin or mucous membranes. The invention is based, at least in part, on the observation that synergistic antimicrobial effects are achieved with combinations of essential oils or individual constituents thereof and low concentrations of quaternary ammonium compounds.
Type:
Application
Filed:
November 29, 2010
Publication date:
March 24, 2011
Inventors:
Shanta M. Modak, Milind S. Shintre, Trupti Gaonkar, Lauserpina Caraos
Abstract: A method for measuring of histamine in an epidermis comprising applying an adhesive article to an epithelium of a mammal; allowing for adherence of epithelial cells to the adhesive article; removing the adhesive article from the epithelium of the mammal; preparing the adhesive article using standard laboratory methods for extraction; extracting histamine from the epithelial cells adhered to said adhesive article; measuring histamine from the epithelial cells adhered to said adhesive article; determining the amount of histamine in the epithelial cells as compared to a baseline sample. Further, a method of objectively measuring the perception of itch in mammals and wherein there is a reduction in histamine from a baseline level which is directly proportional to a reduction in an itch perception.
Type:
Application
Filed:
September 18, 2009
Publication date:
March 24, 2011
Inventors:
James Robert Schwartz, Kathleen Marie Kerr, Patricia West Doyle, Kenneth Robert Wehmeyer, Thomas Massey Burt, Angela Marie Fieno, Rohan Lalith Wimalasena, Gina Marie Fadayel
Abstract: A hydrophilized personal care formulation, which can be in the form of a hand or body soap (liquid or bar), lipstick, body wash, makeup remover, skin cleaner, hair conditioner, skin or hair moisturizer. The formulation employs an organophosphorus material or a mixture of an organophosphorus material, for example, mono-, di-, and polyol phosphate esters.
Type:
Application
Filed:
November 30, 2010
Publication date:
March 17, 2011
Applicant:
Rhodia Inc.
Inventors:
Tobias Johannes FÜTTERER, Lawrence Alan HOUGH, Robert Lee REIERSON
Abstract: Described are personal care compositions, comprising an aqueous dispersion comprising an ethylene acrylic acid copolymer and a least one cosmetically acceptable surfactant, emollient, or cosmetic active.
Type:
Application
Filed:
September 15, 2010
Publication date:
March 17, 2011
Applicants:
Technology Corporation)
Inventors:
Susan L. Jordan, Tatiana V. Drovetskaya
Abstract: The present invention provides methods for treating or preventing diseases and disorders caused by iron-dependent pathogenic microorganisms, such as bacteria, fungi, and parasites, by applying a gallium compound to an affected area. In particular, the present invention provides methods for treating or preventing dental caries, vaginal infections, skin infections, and so forth. Gallium compounds can be formulated as toothpaste, mouthwash, cream, ointment, gel, solution, eye drops, suppository, and the like. Furthermore, the invention provides methods for controlling microbial growth on environmental surfaces, including those of toothbrush, denture, dental retainer, contact lens, catheter, food stuff, and so forth. In addition, the present invention provides animal feeds which contain gallium compounds that promote the animal growth and prevent the animals from infections as well as protect consumers from post processing infections.
Abstract: Disclosed herein are novel zinc ionophores, zinc chelators and/or zinc complexes with enhanced aqueous solubility. Methods of treating cancer using at least one zinc ionophore and/or zinc chelator are also disclosed. Also disclosed herein are compositions and methods for treating cancer with combination therapy using at least one texaphyrin metal complex and at least one zinc ionophore or the respective pharmaceutically acceptable derivatives or salts thereof.
Abstract: The invention provides an oral dosage form for the anti-cancer drug picoplatin comprising a core and a coating, the dosage form being free of redox-active metal salts. The core of the tablet is a substantially dry powder comprising about 10 to 60 wt % picoplatin wherein the picoplatin is a particulate of less than about 10 microns average particle diameter, about 40-80 wt % of a filler comprising a substantially water-soluble, water-dispersible, or water-absorbing carbohydrate, and an effective amount of up to about 5 wt % of a lubricant. The dosage form can further include a dispersant.
Type:
Application
Filed:
August 5, 2009
Publication date:
February 10, 2011
Applicant:
Poniard Pharmaceuticals, Inc.
Inventors:
Alistair J. Leigh, Christopher A. Procyshyn, Ernest S.Y. Wong, Christen M. Giandomenico
Abstract: The invention relates to methods to be used in the maturation of ovarian follicles and oocytes. More specifically, the invention concerns the use of inhibitors of the phosphatase PTEN, such as oxovanadate and peroxovanadate complexes, in methods for in vitro and in vivo maturation of follicles and oocytes.
Abstract: The present invention is related to surfactant-based formulations comprising the polyelectrolytes and blends of such polyelectrolytes with non-cellulosic cationic polysaccharide polymers. The surfactant-based formulations exhibit improved clarity of the resulting formulations, their improved conditioning of keratin substrates, textile substrates, and hard-surface substrates, their improved deposition of dispersed phase materials onto keratin substrates, textile substrates, and hard-surface substrates, their improved lather performance, and their improved rheology in applications such as personal care and household care products and textile applications.
Abstract: The present invention relates to the field of antimicrobial formulations, and more specifically, to an antimicrobial formulation comprising zinc pyrithione in a stabilized dispersion.
Type:
Application
Filed:
May 3, 2010
Publication date:
December 16, 2010
Applicant:
MICROBAN PRODUCTS COMPANY
Inventors:
BURKE I. NELSON, Veronica R. Steinmetz, Ivan Wei-kang Ong
Abstract: The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.
Type:
Application
Filed:
July 13, 2010
Publication date:
December 16, 2010
Applicant:
UNIVERSITY OF SOUTH FLORIDA
Inventors:
HEIDI KAY, JAY W. PALMER, JOSEPH A. STANKO
Abstract: The invention provides formulations for the organoplatinum anticancer drug picoplatin. Self emulsifying compositions, stabilized nanoparticulate compositions, solid dispersions, and nanoparticulate suspensions in oils are provided, along with methods for preparation of the formulations. The formulations can provide improved oral availability of picoplatin relative a to a simple solution of picoplatin such as in water or normal saline solution and can be used in combination therapy.
Type:
Application
Filed:
July 16, 2008
Publication date:
December 9, 2010
Applicant:
Poniard Pharmaceuticals, Inc.
Inventors:
Andrew Xian Chen, Cheni Kwok, Christopher A. Procyshyn
Abstract: A hydrophilic composition and a hydrophilic member obtained by using the composition are provided, which composition contains a hydrophilic polymer having a specific structure of having a hydrolysable group in the side chain thereof in a content of 50% by weight or more based on the weight of the solid components and further contains an additive having an antifungal property, and which composition shows excellent water resistance and maintains the high hydrophilicity even after being stored for a long period under an environment of high temperature and high humidity.
Abstract: The present invention relates to osmium compounds of formula (I), their preparation and use in methods of treatment, particularly for cancer treatment.
Type:
Application
Filed:
August 10, 2007
Publication date:
November 18, 2010
Applicant:
THE UNIVERSITY OF WARWICK
Inventors:
Peter John Sadler, Anna Frances Acushla Peacock, Sabine Helena Van Rijt, Abraha Habtemariam
Abstract: The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.
Type:
Application
Filed:
June 4, 2008
Publication date:
October 21, 2010
Applicant:
Ben-Gurion University of the Negev Research and Development Authority
Inventors:
Aviv Gazit, Shimon Slavin, Esther Priel, Sara Yitzchak
Abstract: The present invention generally relates to the treatment of onychomycosis. More specifically, it relates to combination therapies for the treatment of onychomycosis and related compositions. In a composition aspect, the present invention provides a composition for the treatment of onychomycosis, wherein the composition includes Ciclopirox and at least one other antifungal agent. In a method aspect, the present invention provides a method for treating onychomycosis in a patient suffering from the disease. The method involves topically administering a composition to at least one toe or fingernail of the patient and the composition includes Ciclopirox and at least one other antifungal agent.
Abstract: The present invention provides new Ag(I) complexes with derivatives of nicotinic acid, nicotinamide and related pyridine ligands, and pharmaceutical compositions comprising such Ag(I) complexes for use in the treatment, prophylaxis and prevention of infections. The invention further provides a solvent free method for the synthesis of Ag(I) complexes containing substituted pyridines, pyrazines and pyrimidines as ligands.
Type:
Application
Filed:
June 2, 2008
Publication date:
September 16, 2010
Inventors:
Lars Öhrström, Vratislav Langer, Morsy A.M. Abu-Youssef, Gohar Yoursy, Alshima'a A. Massoud
Abstract: Methods for stabilizing aqueous solutions of picoplatin are provided. Such stable, preferably aseptic solutions are particularly useful for preparing unit dosages of picoplatin for oral or intravenous administration, preferably in combination with at least one additional non-platinum anti-cancer agent.
Type:
Application
Filed:
December 10, 2009
Publication date:
August 26, 2010
Applicant:
Poniard Pharmaceuticals, Inc.
Inventors:
Alistair J. Leigh, Ronald A. Martell, David A. Karlin, Cheni Kwok, Christopher A. Procyshyn, Hazel B. Breitz, Paul L. Weiden
Abstract: The invention relates to the use of C10-C14-alkane-1,2-diols, in particular 1,2-decanediol, 1,2-dodecanediol and/or 1,2-tetradecanediol, in the preparation of a composition for the prophylaxis and/or treatment of Malassezia-induced dandruff formation, as well as to cosmetic and/or dermatological preparations comprising C10-C14-alkane-1,2-diols.
Abstract: Various embodiments of the present invention are directed to hair-loss, and include treatments and preparations. Embodiments of the present invention include bactericides, combinations of bactericides and fungicides, combination of bactericides and vasodilators, and combinations of bactericides, fungicides, and vasodilators that are delivered topically to pilosebaceous units within the scalps of persons suffering from hair loss. The treatment kills or controls microbes that disrupt hair growth by changing, inhibiting, or interrupting one or more biological functions of the pilosebaceous units. Certain embodiments of the present invention contain additional active and inactive ingredients, including anti-inflammatory agents, carriers, emulsifiers, antioxidants, and other such substances.
Abstract: The invention relates to the use of carbon monoxide (CO) to treat infections. The invention also provides novel carbon monoxide releasing molecules (CORMs).
Type:
Application
Filed:
April 24, 2008
Publication date:
August 5, 2010
Applicant:
ALFAMA-Investigacao e Desenvolvimento de produtos Farmaceuticos, Lda
Inventors:
Ligia S. Nobre, Joao D. Seixas, Carlos C. Romao, Ligia M. Saraiva
Abstract: The present invention relates to a stable pyrithione salt polyol dispersion containing a pyrithione salt(s) in particulate form, a polyol and a stabilizer such as a rheological additive. The dispersion can be incorporated into existing polyurethane formulations without additional formula adjustment. Polyurethane foams produced from the composition containing pyrithione salt polyol dispersion of the present invention have more open cell structures, than those produced with a typical commercially available pyrithione salt thus providing a soft comfortable feeling.
Type:
Application
Filed:
January 30, 2009
Publication date:
August 5, 2010
Inventors:
Indulis Gruzins, Kiran B. Chandalia, Brian L. Cooper, Thomas E. Robitaille, Mauricio da Silva Franzim
Abstract: A compound that recognizes and binds to the CA-IX protein has Formula I, II, III, or IV. The compounds may include a radioactive element for radioimaging or therapeutic applications. Thus, pharmaceutical compositions may be prepared with one or more of the compounds of Formula I, II, III, or IV.
Type:
Application
Filed:
December 4, 2009
Publication date:
July 15, 2010
Inventors:
John W. Babich, Craig Zimmerman, John Joyal, Kevin P. Maresca, Genliang Lu, Shawn Hillier
Abstract: A method of treating impaired memory and/or cognitive function by administering one or more chromium complexes, for example chromium picolinate, to an individual in need of improved memory and/or cognitive function. This method is used to improve memory and/or cognitive function associated with various disorders, including Alzheimer's disease, dementia, and mild cognitive impairment (MCI). Chromium complexes for treating memory or cognitive impairment are also disclosed.
Abstract: A compound of Formula I, a pharmaceutically acceptable salt, or solvate thereof: complexes with metals such as rhenium, technetium, and others to provide a complex for imaging tissues or treating disease, particularly where the metal is radioactive. Such complexes are specific to PSMA protein and can therefore be used in imaging or treating cancer of the prostate and other tissue where the protein is expressed.
Type:
Application
Filed:
December 4, 2009
Publication date:
July 15, 2010
Inventors:
John W. Babich, Craig Zimmerman, John Joyal, Kevin P. Maresca, Genliang Lu, Shawn Hillier
Abstract: The invention relates to a composition in the form of an emulsion that can be expanded by an aerosol dispenser, characterised in that it comprises from 15 to 20 volume % of alcohol, from 1 to 10 volume % of C3-C8 polyolen, a thickening agent, at least one non-ionic surfactant, a wetting agent, and one or more active ingredients dissolved or in suspension; the invention also relates to the medical and cosmetic applications thereof.
Abstract: The invention relates to a solid pharmaceutical preparation containing (R)-(?)-2-[5-(4-fluorophenyl-3-pyridylmethylaminomethyl]chroman as an active substance and at least one sugar alcohol (e.g. mannitol, sorbitol) as a filler. Also disclosed is the production of said solid pharmaceutical preparation, which is provided with an increased shelf life also at elevated temperatures and can be used for the treatment of dyskinesia associated with Parkinson's disease.
Type:
Application
Filed:
June 9, 2006
Publication date:
April 29, 2010
Inventors:
Klaus Kunath, Kirstin Heil, Roland Rupp
Abstract: The invention provides an encapsulated unit dosage form for picoplatin that is adapted for oral administration of the picoplatin containing a substantially dry powder with about 20 to 55 wt % picoplatin in the physical form of a picoplatin particulate wherein an average picoplatin particle diameter is less than about 10 microns. The picoplatin particles are dispersed within the powder of the formulation which includes a substantially water-soluble, water-dispersible, or water-absorbing carbohydrate and an effective amount of up to about 5 wt % of a lubricant.
Type:
Application
Filed:
August 5, 2009
Publication date:
March 11, 2010
Applicant:
Poniard Pharmaceuticals, Inc.
Inventors:
Alistair J. Leigh, Christopher A. Procyshyn, Angelica Phillips, Hazel B. Breitz
Abstract: Disclosed are topical compositions for the treatment of microbial infections on the skin or scalp which include a polyvalent metal salt of pyrithione and include a metal ion source. Also disclosed are methods for treating microbial infections of the skin or scalp using such compositions.
Type:
Grant
Filed:
December 8, 2005
Date of Patent:
March 9, 2010
Assignees:
The Procter & Gamble Company, Arch Chemicals, Inc.
Inventors:
David Francis Gavin, Anthony Raymond Marchetta, John Daniel Nelson, Jr., George Polson, James Robert Schwartz, Patricia Aileen Turley
Abstract: Gold(III) phosphine complexes [Aum(CNC)mL]n+ (where HCNCH=2,6-diphenylpyridine) and their use as anti-tumor agents are disclosed. Notable results for the appearance of new potential anti-tumor application of these gold(III) complexes are reported. The described complexes show promising cytotoxic properties toward cancer cells in both in vitro and in vivo studies.
Type:
Grant
Filed:
December 20, 2007
Date of Patent:
December 15, 2009
Assignee:
The University of Hong Kong
Inventors:
Chi Ming Che, Raymond Wai Yin Sun, Zhen Fan Yang, Carrie Ka Lei Li
Abstract: The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens.
Type:
Application
Filed:
May 13, 2009
Publication date:
December 10, 2009
Applicant:
Poniard Pharmaceuticals, Inc.
Inventors:
David A. Karlin, Hazel B. Breitz, Paul L. Weiden
Abstract: Survival of, or axon regeneration in a lesioned mature central nervous system (CNS) neuron is promoted by (a) contacting the neuron with a therapeutically effective amount of an exogenous activator of protein translation; and (b) detecting the resultant promotion of the survival of, or axon regeneration in the neuron.
Type:
Application
Filed:
June 6, 2009
Publication date:
December 10, 2009
Inventors:
Zhigang He, Kevin Park, Kai Liu, Yang Hu
Abstract: The invention provides compounds of formula I: wherein a, b, c, d, n, R1, R2, R3, R6, R7, W, and A are as defined in the specification. The compounds of formula I are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.
Type:
Grant
Filed:
March 9, 2006
Date of Patent:
December 8, 2009
Assignee:
Theravance, Inc.
Inventors:
Yu-Hua Ji, Craig Husfeld, Li Li, Mathai Mammen, YongQi Mu, Eric L. Stangeland
Abstract: Disclosed is a formulation and method for the treatment of fungal infections of the nail (onychomycosis) utilizing a topical composition comprising zinc pyrithione, a solubilizer for the zinc pyrithione, a film former, and a volatile solvent. The formulation is preferably in the form of a lacquer. The composition containing the metal pyrithione complex is topically applied to the infected nail preferably as a nail polish or lacquer which may be applied with a dropper, swab or the like to the afflicted nail surface. The treatment can be done at least two times a day, with a course of treatment lasting from several weeks to several months or until a cure is effected or a significant reduction of the infection is achieved.
Type:
Application
Filed:
June 3, 2008
Publication date:
December 3, 2009
Inventors:
George A. Polson, Katherine P. Roberts, Khat Kevin Lou, Kevin N. DiNicola
Abstract: The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens.
Type:
Application
Filed:
May 12, 2009
Publication date:
November 5, 2009
Applicant:
Poniard Pharmaceuticals, Inc.
Inventors:
David A. Karlin, Hazel B. Breitz, Paul L. Weiden
Abstract: The invention provides supramolecular metal complexes as DNA cleaving agents. In the complexes, charge is transferred from one light absorbing metal (e.g. Ru or Os) to an electron accepting metal (e.g. Rh) via a bridging ?-acceptor ligand. A bioactive metal-to-metal charge transfer state capable of cleaving DNA is thus generated. The complexes function when irradiated with low energy visible light with or without molecular oxygen.
Type:
Grant
Filed:
July 20, 2005
Date of Patent:
November 3, 2009
Assignee:
Virginia Tech Intellectual Properties, Inc.